Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib versus placebo for painful knee osteoarthritis with pain sensitization assessment
ACTRN12609000524291Phase 4Not yet recruiting
- Sponsor
- Curtin University
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of etoricoxib in osteoarthritis (OA) and knee osteoarthritis (OA) (3 arms), sponsored by Curtin University. Primary endpoints: Pressure Pain Threshold and WOMAC pain subscale. Planned start Aug 2009; status: not yet recruiting.
02
Drugs
etoricoxib
03
Conditions
osteoarthritis (OA)knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12609000524291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000524291.